Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
ACBM
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.07
vs -0.07
Q2.23
N/A
-0.05
vs -0.07
Q3.23
N/A
NA
vs NA
Q4.23
N/A
NA
vs NA
Q1.24
N/A
NA
vs NA
Q2.24
N/A
-0.00
vs -0.05
Q3.24
N/A
-0.00
vs NA
Q4.24
N/A
0.18
vs NA
Q1.25
N/A
-0.00
vs NA
Q2.25
N/A
-0.00
vs -0.00
Sales Growth
YoY
Current
Estimates
Q1.23
-100%
NA vs 298.5K
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
NA
-360000.00 vs NA
Q1.25
NA
NA vs NA
Q2.25
NA
NA vs NA
Return on Equity
QoQ
Q1.23
-975%
-9.75
vs -8.09
Q2.23
-941%
-9.41
vs -9.75
Q3.23
NA
NA
vs NA
Q4.23
NA
NA
vs NA
Q1.24
NA
NA
vs NA
Q2.24
+4%
0.04
vs -9.41
Q3.24
+4%
0.04
vs 0.04
Q4.24
-3761%
-37.61
vs 0.04
Q1.25
NA
NA
vs -37.61
Q2.25
NA
NA
vs NA
Institutionnal Ownership
N/A
Q2.23
NA
NA
vs NA
NA
Q3.23
NA
NA
vs NA
NA
Q4.23
NA
NA
vs NA
NA
Q1.24
NA
NA
vs NA
NA
Q2.24
NA
NA
vs NA
NA
Q3.24
NA
NA
vs NA
NA
Q4.24
NA
NA
vs NA
NA
Q1.25
NA
NA
vs NA
NA
Q2.25
NA
NA
vs NA
NA
Q3.25
NA
NA
vs NA
NA
Relative Strength
ACBM
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
2025-Revenue
2025-EPS
2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Acro Biomedical Co., Ltd. engages in developing and marketing of nutritional products. It sells cordycepin and cordyceps powder, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.
OTC
Pre-market 0.00$
0.00 (0.00%)
Relative Strenght
Volume Buzz
-99%
Earning Acce
No
Dist 52w H.
100%Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How ACBM compares to sector?